Leukocyte Adhesion Deficiency – Causes, Symptoms, Treatment

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 10 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Leukocyte Adhesion Deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder. Leukocyte adhesion deficiency (LAD), is a rare autosomal recessive disorder characterized by immunodeficiency resulting in recurrent infections.[rx] LAD is currently divided into three subtypes: LAD1, LAD2, and the...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Leukocyte Adhesion Deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder. Leukocyte adhesion deficiency (LAD), is a rare autosomal recessive disorder characterized by immunodeficiency resulting in recurrent infections.[rx] LAD is currently divided into three subtypes: LAD1, LAD2, and the recently described LAD3, also known as LAD-1/variant. In LAD3, the immune defects are supplemented by a Glanzmann thrombasthenia-like bleeding tendency.[rx][rx] Other Names...

Key Takeaways

  • This article explains Types of Leukocyte Adhesion Deficiency in simple medical language.
  • This article explains Pathophysiology in simple medical language.
  • This article explains Causes of Leukocyte Adhesion Deficiency in simple medical language.
  • This article explains Symptoms of Leukocyte Adhesion Deficiency in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.

infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte Adhesion Deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder.

infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte adhesion deficiency (LAD), is a rare autosomal recessive disorder characterized by immunodeficiency resulting in recurrent infections.[rx] LAD is currently divided into three subtypes: LAD1, LAD2, and the recently described LAD3, also known as LAD-1/variant. In LAD3, the immune defects are supplemented by a Glanzmann thrombasthenia-like bleeding tendency.[rx][rx]

Other Names for This Condition

  • LAD1
  • leucocyte adhesion deficiency type 1
  • infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte adhesion molecule deficiency type 1

Types of infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte Adhesion Deficiency

Three different types of syndromes have been identified:

  • infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte adhesion deficiency 1: Deficient or defective beta-2 integrin family
  • infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte adhesion deficiency 2: Absent fucosylated carbohydrate ligands for selectins
  • infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte adhesion deficiency 3: Defective activation of all beta integrins (1, 2, and 3)

Type 1 results from mutations in the integrin beta-2 gene (ITGB2), encoding CD18 of beta-2 integrins. Type 2 results from mutations in the glucose diphosphate (GDP)-fucose transporter gene. Type 3 is caused by mutations in the FERMT3 gene (11q13.1), which encodes kindlin-3 in hematopoietic cells.

Pathophysiology

Deficiency of the following integrins: LFA-1/Mac-1, p150 and p95 cause the immunologic and clinical abnormalities seen in infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte adhesion deficiency. These proteins functions as adhesion molecules. They are present on lymphocytes, granulocytes, monocytes, and large granular lymphocytes. LFA-1, Mac-1, and glycoprotein 150/95 have a common beta chain but have distinct alpha chains denominated M1 (Mac-1 molecule), L1 (LFA-1 molecule), and X1 (p150,95 molecules). A defect in the beta subunit is accountable for the decreased expression of LFA-1/Mac-1 polypeptide. Natural killer cell activity is not affected. The ulcer. সহজ বাংলা: শরীরের অস্বাভাবিক দাগ, ক্ষত বা ফোলা অংশ।" data-rx-term="lesion" data-rx-definition="A lesion is an abnormal area of tissue such as a spot, wound, patch, lump, or ulcer. সহজ বাংলা: শরীরের অস্বাভাবিক দাগ, ক্ষত বা ফোলা অংশ।">lesion is on chromosome 21, noted in some patients studied by molecular biology techniques.

Causes of infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte Adhesion Deficiency

Primarily, leukocytes cannot escape from the blood to tissues that have been attacked by microbes. Continuous surveillance of foreign antigens by infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte trafficking suffers disruption as well. There are three different types of LAD:

  • Type I – in which steady adhesion of infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte to endothelial surfaces is defective by mutations in CD18 gene resulting in defective or deficient beta-2 integrin
  • Type II – in which there is an absence of Sialyl Lewis X of E-selectin
  • Type III – in which there is a defect in beta integrins 1, 2, and 3; this impairs the integrin activation cascade – specifically, a mutation in the kindlin-3 gene causes this type of LAD

LAD has an autosomal recessive mode of inheritance.

  • Seven new mutations in the ITGB2 gene reported, which encode the beta2 integrin family including three frameshift deletions (Tyr382fsX9, Asn282fsX41, and Lys636fsX22), two splicing (IVS4-6C>A, IVS7+1G>A) and three missense (Asp128Tyr, Gly716Ala, and Ala239Thr).

Mutations in the ITGB2 gene cause infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte adhesion deficiency type 1. This gene provides instructions for making one part (the β2 subunit) of at least four different proteins known as β2 integrins. Integrins that contain the β2 subunit are found embedded in the membrane that surrounds white blood cells (leukocytes). These integrins help leukocytes gather at sites of infection or injury, where they contribute to the immune response. β2 integrins recognize signs of pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation and attach (bind) to proteins called ligands on the lining of blood vessels. This binding leads to linkage (adhesion) of the leukocyte to the blood vessel wall. Signaling through the β2 integrins triggers the transport of the attached leukocyte across the blood vessel wall to the site of infection or injury.

ITGB2 gene mutations that cause infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte adhesion deficiency type 1 lead to the production of a β2 subunit that cannot bind with other subunits to form β2 integrins. Leukocytes that lack these integrins cannot attach to the blood vessel wall or cross the vessel wall to contribute to the immune response. As a result, there is a decreased response to injury and foreign invaders, such as bacteria and fungi, resulting in frequent infections, delayed wound healing, and other signs and symptoms of this condition.

Symptoms of infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">Leukocyte Adhesion Deficiency

Symptoms of infection. সহজ বাংলা: শ্বেত রক্তকণিকা।" data-rx-term="leukocyte" data-rx-definition="Leukocyte means white blood cell, which helps fight infection. সহজ বাংলা: শ্বেত রক্তকণিকা।">leukocyte adhesion deficiency usually begin in infancy.

  • There is an inability to form pus.
  • There is a deficiency of various glycoproteins including LFA-1/Mac-1, glycoprotein 150/95.
  • Leukocytes cannot migrate to infection sites to kill invading microorganisms due to mutations in the CD18 glycoprotein.
  • Adhesion molecules deficiency results in abnormal inflammatory response and eventually recurrent bacterial infections.
  • Severely affected infants have recurrent or progressive necrotic soft-tissue infections with staphylococcal and gram-negative bacteria, periodontitis, poor wound healing, no pus formation, leukocytosis, and delayed (> 3 weeks) umbilical cord detachment. WBC counts remain high even between infections. Infections become increasingly difficult to control.
  • Less severely affected infants have few serious infections and mild alterations in blood counts.
  • Developmental delay is common in type 2.

Diagnosis of Leukocyte Adhesion Deficiency

Characteristically, biopsy of infected tissue demonstrates inflammatory infiltrates completely devoid of neutrophils. Remnants of the umbilical cord can show a loose edematous tissue with remarkably few inflammatory cells. In contrast, there is an elevated level of peripheral blood leucocytes (over 29000/microliters) due to an impaired mobilization of leukocytes to extravascular sites of inflammation.

History and Physical

The classic presentation of leukocyte adhesion deficiency is recurrent bacterial infections, neutrophil adhesion defects, and umbilical cord sloughing delays. The adhesion defects result in poor leukocyte chemotaxis, particularly the neutrophil, with an inability to form pus and neutrophilia.

Individuals with leukocyte adhesion deficiency commonly suffer from bacterial infections beginning in the neonatal period. Infections such as omphalitis, pneumonia, gingivitis, and peritonitis are common and usually life-threatening due to the inability to destroy the invading pathogens. Individuals with LAD do not form abscesses because granulocytes cannot migrate to the sites of infection.

Characteristics of patients with LAD include the following:

LAD I:

  • Delayed separation of the umbilical cord
  • Recurrent pyogenic infections, with onset in the first weeks of life
  • Infections caused meanly by Staphylococcus aureus and Pseudomonas aeruginosa
  • Absent pus formation
  • Periodontitis

LAD II:

  • Recurrent skin infections
  • Pneumonia
  • Bronchiectasis
  • Tuberculosis
  • Denture abnormalities
  • Infections are less severe and fewer as compared to LAD I

LAD III:

  • Omphalitis
  • Osteoporosis like bone features
  • Bleeding complications
  • Hematological abnormalities, e.g., bone marrow failure
Other miscellaneous manifestations may include:
  • Vaginitis
  • Peritonitis
  • Osteomyelitis
  • Perianal abscesses
  • Sinusitis
  • Tracheobronchitis
  • Necrotic soft tissue infections
  • Otitis media
  • Meningitis
  • Graft versus host reaction
  • Recurrent tonsillitis
  • Conjunctivitis
  • Granuloma
  • Oral candidiasis
  • Aphthous stomatitis
  • Urinary tract infections
  • Lymphocytic interstitial pneumonitis
  • Glomerulonephritis
  • Hemolytic-uremic syndrome
  • Nail dystrophy
  • Persistent Hyperinsulinemic hypoglycemia of infancy
  • Pyoderma gangrenosum
  • Megakaryocytic acute myeloid leukemia

Evaluation

The immunological investigation of a patient with leukocyte adhesion deficiency includes:

Flow Cytometry Analysis (definitive test)

  • Demonstrates the absence of functional CD18 and the associated alpha subunit molecules on the surface of leukocytes using CD11 and CD18 monoclonal antibodies (LAD I)
  • Demonstrates the absence of sialyl Lewis X expression (CD15a) using a monoclonal antibody directed against sialyl Lewis X ( LAD-II)

Sequence analysis using genetic testing

  • To define the exact molecular defect in the beta-2 subunit

Quantitative Serum Immunoglobulins

  • IgG
  • IgM
  • IgA
  • IgE

Antibody Activity

IgG antibodies (post-immunization)

  • Tetanus toxoid
  • Diphtheria toxoid
  • Pneumococcal polysaccharide
  • Polio

IgG antibodies (post-exposure)

  • Rubella
  • Measles
  • Varicella Zoster

Detection of isohemagglutinins (IgM)

  • Anti-type A blood
  • Anti-type B blood

Other assays

  • Test for heterophile antibody
  • Anti-streptolysin O titer
  • Immunodiagnosis of infectious diseases (HIV, hepatitis B, and C, HTLV and dengue)
  • Serum protein electrophoresis

Blood lymphocyte subpopulations

  • Total lymphocyte count
  • T lymphocytes (CD3, CD4, and CD8)
  • B lymphocytes (CD19 and CD20)
  • CD4/CD8 ratio

Lymphocyte stimulation assays

  • Phorbol ester and ionophore
  • Phytohemagglutinin
  • Antiserum to CD3
  • Chemotaxis of human lymphocytes
Phagocytic function

Nitroblue tetrazolium (NBT) test (before and after stimulation with endotoxin)

  • Unstimulated
  • Stimulated

Neutrophil mobility

  • In medium alone
  • In the presence of chemoattractant
  • In vivo and in vitro chemotaxis of granulocytes
Complement System Evaluation

Measurement of individuals components by immunoprecipitation tests, ELISA, or Western blotting

  • C3 serum levels
  • C4 serum levels
  • Factor B serum levels
  • C1 inhibitor serum levels

Hemolytic assays

  • CH50
  • CH100

Complement system functional studies

  • Classical pathway assay (using IgM on a microtiter plate)
  • Alternative pathway assay (using LPS on a microtiter plate)
  • Mannose pathway assay (using mannose on a microtiter plate)

Microbiological studies

  • Nasopharyngeal swab (testing for Rhinovirus)
  • Stool (testing for viral, bacterial or parasitic infection)
  • Sputum (bacterial culture and pneumocystis PCR)
  • Blood (bacterial culture, HIV by PCR, HTLV testing)
  • Urine (testing for cytomegalovirus and proteinuria)
  • Cerebrospinal fluid (culture, chemistry, and histopathology)

Other investigations of immunodeficiency disorders

  • Bone marrow biopsy
  • Complete blood cell count
  • Blood chemistry
  • Histopathological studies
  • Tumoral markers
  • Levels of cytokines
  • Chest x-ray
  • Diagnostic ultrasound
  • Liver function test

Treatment of Leukocyte Adhesion Deficiency

  • The treatment of LAD-I is allogeneic hematopoietic stem cell transplant (HSCT). By the age of 2 years, the disease is fatal in severe cases without HSCT.
  • Ustekinumab, a monoclonal antibody of the p40 subunit common to IL-12 and IL-23, had been used successfully to treat refractory periodontitis and sacral ulcer in a case report with mild LAD I. However, further studies are necessary to determine safety and efficacy, particularly in patients with more severe disease.
  • Recombinant human interferon-gamma treatment has been used in LAD-I. 
  • A trial of fucose supplementation is recommended in all patients diagnosed with LAD II
  • Recombinant factor VIIa is considered effective in treating and preventing severe bleeding in a child patient with LAD III 
  • Use of prophylactic immunoglobulin therapy was successful in two patients with a severe form of LAD.
  •   Although patients can receive intensive antibiotherapy and even granulocyte transfusions from healthy donors, the only current curative therapy is the hematopoietic stem cell transplant.[rx] However, progress has been made in gene therapy, an active area of research. Both foamyviral and lentiviral vectors expressing the human ITGB2 gene under the control of different promoters have been developed and have been tested so far in preclinical LAD-I models (such as CD18-deficient mice and canine leukocyte adhesion deficiency-affected dogs).
  • More conservative treatment is directed against specific infectious agents. Patients are infected with common pathogenic agents but no with opportunistic ones and should respond well to antimicrobial therapy. The most common pathogens affecting patients with LAD include Proteus, Klebsiella, Staphylococcus aureus, Pseudomonas aeruginosa, and enterococci.  Early aggressive treatment should be used or given as prophylactic therapy (e.g., dental procedures).
The differential diagnosis for neutrophilia includes the following
  • Marrow storage pool shift (inflammation/infection) – Acute neutrophilia from a leukemoid reaction due to the release of neutrophils from the marrow storage pool, due to inflammation and/or infection. Increased numbers of neutrophil bands are usually observed.
  • Pseudoneutrophilia (stress demargination) – Acute temporary neutrophilia as a response caused by a shift of cells from the marginal to the circulating pool, secondary to vigorous exercise or acute physical or emotional stress. Neutrophil counts may be doubled, but lymphocytes and monocytes are generally unaffected by demargination.
  • Myeloproliferative disorder – Juvenile myelomonocytic leukemia can present in infancy with fever, persistent infection, skin and oral bleeding. The leukocyte count is elevated but the differential reveals immature myeloid cells, blasts, and nucleated red cells.
  • Leukocyte adhesion deficiencyn – type II – Leukocyte adhesion deficiency- type II (LAD-II) is similar to LAD-I as it presents with neutrophilia but results from a defect in fucose metabolism causing the absence of Sialyl Lewis X and other fucosylated ligands for the selectins. It is extremely rare and is associated with the Bombay Blood group and mental retardation.
  • Leukocyte adhesion deficiency type III – Leukocyte adhesion deficiency- type III (LAD-III) is similar to LAD-I as it presents with neutrophilia and is due to a defect in integrin activation affecting both neutrophils and platelets. It is extremely rare and is also associated with a bleeding phenotype.
  • Transient myeloproliferative disorder – Leukocytosis with circulating blasts found in infants with Down syndrome or mosaicism for trisomy 21 is associated with GATA-binding factor 1 (GATA1) mutation. Infants often also have hepatosplenomegaly. Median age of presentation is 3 to 7 days with the majority of cases diagnosed prior to age 2 months. Self-resolves by 3 to 6 months in most cases; however, symptomatic infants may require cytarabine.
The differential diagnosis for delayed umbilical separation includes the following
  • Physiologic umbilical separation – A well infant with delayed separation of the umbilical cord and normal blood counts is extremely unlikely to have LAD-I. The mean time of umbilical cord separation is 13.9 days; however, normal infants are documented to have cord separation from 3 to 45 days.
  • Urachal cyst

References

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Drink safe fluids and monitor temperature.
  • In dengue-prone areas, discuss CBC and platelet count when fever persists or warning signs appear.
  • Use tepid sponging for high fever discomfort; avoid ice-cold bathing.

OTC medicine safety

  • For fever, common fever medicine may be discussed with a clinician or pharmacist.
  • Avoid aspirin/ibuprofen-like medicines in suspected dengue unless a doctor says it is safe.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Fever with breathing difficulty, confusion, repeated vomiting, bleeding, severe weakness, stiff neck, or dehydration needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Medicine doctor / pediatrician for children / qualified clinician
Tests to discuss with doctor
  • Temperature chart and hydration assessment
  • CBC with platelet count if fever persists or dengue/other infection is possible
  • Urine test, malaria/dengue tests, chest evaluation, or blood culture only when clinically indicated
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Do I need antibiotics, or is this more likely viral?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Leukocyte Adhesion Deficiency – Causes, Symptoms, Treatment

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Combined Immunodeficiency with Childhood-Onset Kaposi Sarcoma

    Combined immunodeficiency with childhood-onset Kaposi sarcoma is a very rare genetic immune system disease. In this disease, a gene called TNFRSF4 does not work properly. This...

    February 14, 2026 • Rx Cancer (A - Z)
  2. Collecting Duct Renal Cell Carcinoma

    Collecting duct renal? cell carcinoma is a rare and very aggressive type of kidney cancer. It starts in the small tubes at the very end of...

    February 10, 2026 • Rx Cancer (A - Z)
  3. Collecting Duct Carcinoma of the Kidney

    Collecting duct carcinoma of the kidney is a very rare and very aggressive type of kidney cancer. It starts in the last part of the kidney...

    February 10, 2026 • Rx Cancer (A - Z)
  4. Kidney Collecting Duct Carcinoma

    Kidney collecting duct carcinoma is a rare, very aggressive type of kidney cancer. It starts in the tiny tubes at the end of the kidney’s filtering...

    February 10, 2026 • Rx Cancer (A - Z)
  5. Carcinoma of the Collecting Duct of the Renal Tubule

    Carcinoma of the collecting duct of the renal? tubule is a rare and very aggressive cancer that starts in the tiny tubes in the middle part...

    February 10, 2026 • Rx Cancer (A - Z)
  6. Bellini Carcinoma

    Bellini carcinoma is a very rare and very aggressive type of kidney cancer. It starts in the last part of the tiny tubes in the kidney...

    February 10, 2026 • Rx Cancer (A - Z)
  7. Collecting Duct Carcinoma

    Collecting duct carcinoma is a rare and very aggressive type of kidney cancer. It starts in the tiny tubes at the end of the kidney’s filtering...

    February 10, 2026 • Rx Cancer (A - Z)
  8. Paediatric Kidney Clear Cell Sarcoma

    Paediatric kidney clear cell sarcoma (often shortened to clear cell sarcoma of the kidney, CCSK) is a rare type of kidney cancer that happens mainly in...

    January 29, 2026 • Rx Cancer (A - Z)
  9. Clear Cell Sarcoma of the Kidney (CCSK)

    Clear cell sarcoma of the kidney (CCSK) is a rare type of kidney cancer that happens mostly in young children, usually under 5 years of age....

    January 29, 2026 • Rx Cancer (A - Z)
  10. Cystic-Multilocular Variant; Grawitz Tumor

    Cystic-multilocular variant; Grawitz tumor is a type of kidney cancer that forms many fluid-filled spaces (cysts) separated by thin walls inside the kidney. It belongs to...

    January 28, 2026 • Rx Cancer (A - Z)